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Abstract
Preterm birth (PTB), defined as a delivery before 
37 weeks of gestation, is the leading cause of perinatal 
morbidity and mortality worldwide. Diagnosis of 
preterm labour as well as accurate prediction of PTB 
is notoriously difficult. Preterm birth is initiated 
by multiple mechanisms including infection or 
inflammation which is the only pathological process 
for which a firm causal link with PTB has been 
established. Intrauterine infection evokes an immune 
response that involves the release of cytokines and 
chemokines, prostaglandins and matrix-degrading 
enzymes. These substances trigger uterine contractions, 
membrane rupture and cervical ripening. Most intra-
uterine infections are chronic and subclinical in nature 
and consequently hard to diagnose before labour or 
rupture of the membranes. The best studied site of 
infection is amniotic fluid, but this requires an invasive 
procedure. A non-invasive approach seems to be more 
relevant to clinical practice. However, few studies 
have investigated the maternal inflammatory response 
during preterm labour. Therefore, the overall objective 
of this study was to determine several inflammatory 
markers in maternal serum from pregnant women 
in labour (either term or preterm) vs. non-labouring 
controls. 
We completed a nested case control study in which 
singleton pregnancies were recruited at Ghent 
University Hospital and divided into groups 
according to gestational age and labour status. 
Multiple proteins were evaluated in maternal 
serum using enzyme-linked or multiplex bead 
immunoassays including soluble triggering receptor 
expressed on myeloid cells-1 (sTREM-1), matrix 
metalloproteinases (MMP)-9 and MMP-3, tissue 
inhibitor of metalloproteinases (TIMP)-1, TIMP-2, 
TIMP-3 and TIMP-4 and a panel of 30 cytokines, 
chemokines and growth factors.
Key words: preterm labor, maternal serum, human 
parturition, sTREM-1, MMP, TIMP, MMP:TIMP im-
balance, biomarkers, cytokines.
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Preterm birth rates have increased in most 
industrialized and many developing countries (Beck 
et al., 2010; Blencowe et al., 2012; Goldenberg 
et al., 2008). Also in Flanders, the PTB rate has 
increased from 5.3% in 1991 to 7.6% in 2012, but 
the number remained relatively stable during the 
last 10 years (2001-2011) (Cammu et al., 2012). 
Keirse et al. (2009) examined the pattern of PTB 
over a 12-year period (1991-2002) and showed that 
there was an almost linear increase in PTB rate of 
0.23% a year (Keirse et al., 2009).
Despite advances in perinatal medicine, improved 
perinatal health indicators and advancing knowledge 
of risk factors and mechanisms associated with 
PTB, there has been little progress in reducing 
PTB rate (Goldenberg et al., 2008; Khan and 
Honest, 2007; Kramer et al., 2012). Prediction and 
prevention remains difficult and poses a continuing 
and significant challenge to modern obstetrics. 
An increasing number of maternal and foetal risk 
factors have been associated with PTB (Table I), 
but the precise mechanisms by which risk factors 
are related to PTB are often unknown (Goldenberg 
et al., 2008). 
Infection and inflammation are important mech-
anisms leading to PTB. Intrauterine infection is the 
Introduction
Preterm birth (PTB), referring to all births before 
37 completed weeks of gestation, is a major perinatal 
health problem because it is the leading cause of 
perinatal morbidity and mortality worldwide (Beck 
et al., 2010; Goldenberg et al., 2008). Although sur-
vival rates have markedly improved over the last 
15 years, these infants have an increased risk of 
neurodevelopmental impairments and respiratory 
and gastrointestinal complications (Goldenberg et 
al., 2008). The serious effects of PTB on parents, 
infant and society make PTB an important issue to 
public health worldwide (Khan and Honest, 2007).
In 2010, the global incidence of PTB has been 
estimated at 11.1% of all births, with 14.9 million 
PTBs occurring annually (Blencowe et al., 2012). 
Europe has the lowest rate of PTB worldwide with 
prevalence’s varying from 5.5% to 11.4, with an 
average of 7.1% (or 500 000 births annually) (Keller 
et al., 2011). In Flanders, 7.6% of the babies were 
born preterm in 2012. In singleton pregnancies about 
6.7% of the deliveries (n = 4395) occur preterm, 
while in multiple pregnancies, accounting for 1.8% 
of the deliveries in Flanders, 59.4% (n = 717) ended 
preterm (Cammu et al., 2012).
Table I. — Risk factorsfor preterm birth*
Primary risk factors Secondary risk factors
Sociodemographic factors Biophysical predictors
Black race
Low socioeconomic and educational status
Low (<18 years) and high (> 40 years) maternal age
Single marital status
Digital examination
Short cervix
Absence of foetal breathing movements
Lifestyle, psychosocial and environmental factors Biochemical predictors (non-exhaustive)
Smoking, cocaine and heroin use
Heavy alcohol consumption
Hard working conditions
Anxiety, stress and depression
Low and high prepregnancy body-mass index (BMI)
Cervicovaginal foetal fibronectin (fFN)
Cervicovaginal phosphorylated form of insulin-like growth factor 
binding protein 1 (phIGFBP-1)
Cervicovaginal β-human chorionic gonadotropin (β-hCG)
Cervicovaginal interleukin-8 (IL-8)
Plasma matrix metalloproteinase-9 (MMP-9)
Maternal serum and amniotic fluid C-reactive protein (CRP)
Amniotic fluid interleukin-6 (IL-6)
Insulin-like growth factor binding protein 1 (IGFBP-1)
Placental alpha macroglobulin-1 (PAMG-1)
Obstetrical history and pregnancy characteristics
Previous preterm birth
Second trimester pregnancy loss
Multiple pregnancy and higher order pregnancy
Short interpregnancy interval (< 6 months)
Singleton pregnancy after in-vitro fertilisation
Inadequate prenatal care
Low gestational weight gain
Vaginal bleeding
Infection/inflammation
Extreme amniotic fluid volume (oligo- or polyhydramnios)
Abdominal surgery in the 2nd or 3rd trimester
Cervical procedures
Uterus anomalies
* Modified after Goffinet, F. BJOG, 2005; Goldenberg, RL et al. Lancet, 2008; Honest, H. et al. Health Technol Assess,2009.
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et al., 2011). Moreover, it has been shown that 
sTREM-1 levels reflect the infection status more 
accurately than C-reactive protein (CRP) and pro-
calcitonin (PCT) levels do (Su et al., 2012). 
Few studies have investigated the role of sTREM-1 
in PTB. Menon and Fortunato (2008) demonstrated 
that both lipopolysaccharide (LPS) and preterm la-
bour induced foetal membrane TREM-1 expression. 
In the presence of IUI, amni otic fluid sTREM-1 
concentrations were significantly higher in patients 
with preterm labour or PPROM (Kusanovic et al., 
2010; Menon and Fortunato, 2008). To our knowl-
edge, only two studies (Cobo et al., 2013; Tsiartas 
et al., 2012) evaluated serum sTREM-1 concen-
trations during preterm labour. However, these 
studies did not include women with term labour. 
There is accumulating evidence that inflammation 
has also been implicated in the mechanism of spon-
taneous term parturition (Romero et al., 2006) and 
upregulation of sTREM-1 in myometrium and cer-
vix has been demonstrated with the onset of term 
labour (Youssef et al., 2009). Therefore, the pur-
pose of this study was to assess sTREM-1 concen-
trations in maternal serum during term and preterm 
labour. 
Objective 2: To determine the maternal serum con-
centrations of MMP-3, MMP-9 and all four TIMPs 
as well as the MMP:TIMP ratios during term and 
preterm labour 
Matrix metalloproteinases (MMPs) are proteolyt-
ic, zinc-dependent enzymes, capable of degrading 
extracellular matrix (ECM) components, including 
collagen. Their activity is regulated by tissue inhib-
itors of metalloproteinases (TIMPs) of which four 
have been identified, TIMP-1 through TIMP-4. Inhi-
bition of MMP activity occurs in a 1:1 stoichiomet-
ric relationship. The balance between collagenoly-
sis and its inhibition is critical during ECM remod-
elling. An imbalanced MMP:TIMP ratio has been 
involved in various medical conditions in humans 
including cancer, rheumatoid arthritis, osteoarthri-
tis, endometriosis and vascular diseases (Amalinei 
et al., 2007; Brew and Nagase, 2010).
Human pregnancy is characterized by a steady 
remodelling of the collagenous ECM in order to 
adapt foetal membranes and cervix to uterine and 
foetal growth as gestation progresses. Matrix metal-
loproteinases are undoubtedly involved in ECM 
remodelling during pregnancy as well as in the 
generation of labour through membrane weaken-
ing and rupture and cervical ripening and dilata-
tion (Cockle et al., 2007; Weiss et al., 2007). Some 
MMPs (e.g. MMP-1, MMP-2 and MMP-3) are 
constitutively expressed during gestation, while the 
only pathological process for which both a firm 
causal link with PTB has been established and a 
direct molecular pathophysiology defined (Golden-
berg et al., 2008; Romero et al., 2006). Intrauterine 
infection evokes an immune response that involves 
the release of cytokines and chemokines, prosta-
glandins and matrix-degrading enzymes. These 
substances trigger uterine contractions, membrane 
rupture and cervical ripening. However, most intra- 
uterine infec tions are chronic and subclinical in 
nature and consequently hard to diagnose before 
labour or rupture of the membranes (Goldenberg 
et al., 2000). Therefore, tremendous research ef-
forts have been performed to identify inflammatory 
markers to predict PTB in both asymptomatic and 
symptomatic women and to improve our under-
standing of the mechanisms and pathways leading 
to PTB. Despite these efforts, the puzzle of PTB 
seems far from being resolved, at least because the 
nature of PTB is heterogeneous and complex, but 
also because the process of term labour is poorly 
understood. The best studied site of infection is 
amniotic fluid. Although these studies increase our 
understanding in the foetal inflammatory response, 
it is unlikely that one will perform invasive proce-
dures to test foetal biomarkers for the prediction of 
PTB. A non-invasive approach (e.g. maternal blood, 
vaginal or cervical secretions) seems to be more rel-
evant to clinical practice because of the feasibility 
and accessibility. Therefore, the overall objective of 
this thesis was to determine several inflammatory 
markers in maternal serum from pregnant women 
in labour (either term or preterm) vs. non labouring 
controls.
Objectives
Objective 1: To assess sTREM-1 concentrations in 
maternal serum during term and preterm labour
Recently, a family of cell surface receptors, the trig-
gering receptor expressed on myeloid cells (TREM) 
proteins, has been discovered that seems to play an 
important role in fine-tuning the immune response 
during infectious diseases. TREM-1 is a transmem-
brane glycoprotein, mainly expressed in monocytes 
and neutrophils (Bouchon et al., 2001). It has been 
demonstrated that sTREM-1 is involved in bacteri-
al infection (Jiyong et al., 2009) as well as in non-
infectious inflammatory conditions (Collins et al., 
2009; Park et al., 2009). Research in septic patients 
demonstrated that sTREM is of substantial value 
for early diagnosis of bacterial infection (Jiyong et 
al., 2009), and represents an excellent biomarker for 
the prognosis of sepsis (Gibot et al., 2005), bacter-
aemia (Su et al., 2012) and sepsis severity (Zhang 
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a nested case-control study after the major 
outcomes (such as PTB before 34 weeks’ gestation) 
were determined. All subjects for this study, except 
patients from group 2 (see below), were selected 
from the original cohort. A convenience sample 
of singleton pregnancies was selected and divided 
into four groups according to gestational age (GA) 
and labour status. Table II provides an overview 
of the study population and immunoassays for the 
different inflammatory markers. 
Group 1 consisted of women with preterm la-
bour, allocated to the PTB group when delivered 
before 34 weeks gestation ( = PTB), including pa-
tients with preterm prelabour rupture of the mem-
branes (PPROM) or with preterm labour (PTL) and 
intact membranes. Group 2 consisted of women not 
in labour, attending the prenatal clinic and matched 
for week of gestation with the PTB group. All these 
women had an uncomplicated pregnancy that pro-
ceeded to term delivery ( = GA matched controls). 
Group 3 consisted of healthy pregnant women at 
term in labour ( = AT in labour), including patients 
in labour with intact membranes and women with 
prelabour rupture of the membranes (PROM). 
Group 4 consisted of healthy pregnant women at 
term not in labour, undergoing a primary Caesarean 
section ( = AT not in labour).
Eligibility criteria included age ≥ 18 years, ges-
tational age ≥ 24 weeks, absence of foetal (con-
genital) malformations, absence of infectious dis-
ease or acute infection and Dutch speaking. Data on 
maternal demographics, medical and obstetrical his-
tory and pregnancy outcome were recorded. Written 
informed consent was obtained from every patient. 
The study was approved by the Ethical Committee 
of Ghent University Hospital (EC/2009/010).
Sample collection, processing and analysis
Blood samples of labouring women (either term or 
preterm) were collected by the attending midwife 
upon admission to the labour and delivery ward 
using serum separating tubes. Women at term not 
in labour were sampled prior to their Caesarean 
section. Gestational age matched controls were 
enrolled from the prenatal clinic. These pregnant 
women were screened at 20-22 weeks (structural 
ultrasound) to verify whether they fulfilled the 
inclusion criteria. These women were matched for 
week of gestation with a PTB case. Sampling was 
performed during a subsequent prenatal consultation 
at the appropriate gestational age.
Samples were stored at 4°C until centrifugation. 
Blood samples were centrifuged at 1000 g for 
10 minutes at room temperature to harvest serum. 
All samples were stored at -80 °C until analysis. 
production of others (e.g. MMP-9) are induced by 
active labour (Cockle et al., 2007). Aberrant ECM 
degradation by MMPs or imbalanced MMP:TIMPs 
ratios have been implicated in the pathogenesis of 
preterm labour. Intrauterine infection triggers MMP 
production via inflammatory mediators (Golden-
berg et al., 2000). Activation of the MMP cascade 
causes ECM degradation, predisposing membrane 
rupture and cervix ripening (Cockle et al., 2007). 
The involvement of MMP-9 in IUI and parturition 
has been clearly demonstrated in amniotic fluid, but 
few studies have investigated MMP-3. The majori-
ty of studies focused only on TIMP-1 and TIMP-2 
concentrations in amniotic fluid. Few studies have 
investigated MMPs or TIMPsin maternal serum. 
We hypothesized that aberrant MMP expressions at 
local level implicated in ECM degradation of the 
chorio-amnion and cervix, are associated with aber-
rant changes in circulating MMPs, resulting in im-
balanced MMP:TIMP ratios and leading to preterm 
labour. We therefore sought to determine the mater-
nal serum concentrations of MMP-3, MMP-9 and 
all four TIMPs as well as the MMP:TIMP ratios 
during term and preterm labour. 
Objective 3: To evaluate the maternal inflammatory 
response during term and preterm labour by simul-
taneous measurement of 30 biomarkers in maternal 
serum 
Human term and preterm parturition are inflam-
matory processes in which cytokines play a pivot-
al role. Deregulated cytokine networks may lead 
to adverse pregnancy outcomes such as preterm 
labour. A number of studies have explored amni-
otic fluid cytokine profiles in women with PTB, but 
few studies have evaluated circulating cytokines 
during term and preterm labour. We hypothesized 
that inflammatory serum markers are differently ex-
pressed in labour, especially in women with preterm 
labour. Therefore, we sought to evaluate a panel of 
relevant maternal cytokines in labouring vs. non 
labouring women (either term or preterm) by using 
a multiplex immunoassay. This novel technological 
approach makes it possible to measure multiple pro-
teins simultaneously, thereby requiring only small 
sample volumes. 
Materials and Methods
Study design and study population
An observational study was conducted and included 
768 pregnant women between 24 and 42 weeks’ 
gestation, presenting to the labour and delivery 
ward of Ghent University Hospital. We completed 
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The subgroups were translated into three 
variables: preterm (vs. at term), labour (vs. not 
in labour) and rupture of membranes (ROM) (vs. 
intact membranes). Because these key covariates 
were the focus of our investigation, they remained 
in the models regardless of their significance. 
To adjust for possible confounding effects, the 
following covariates were considered in the model 
selection procedure: maternal age, education level, 
marital status, smoking, BMI, history of PTB, 
storage time and time delay between sampling 
and processing (referred to as sample age). This 
set of covariates was included in the initial model 
of the selection procedure for each outcome. 
Model selection was carried out for each outcome 
independently and occurred in two steps. First, a 
backward selection of main terms was applied in 
which covariates were sequentially removed in 
order of increasing significance until only terms with 
p-value below 0.10 remained. In the second step, 
first order interactions were considered between 
the covariates remaining in the model. The forward 
selection of interaction terms was performed with 
an inclusion criterion of p  = 0.05. When no further 
interactions met this criterion, the final model was 
obtained for that outcome.
All statistical analyses and tests were performed 
two-sided at the 5% significance level using SPSS 
statistics 19 software (IBM, Chicago, Illinois).
sTREM-1 concentrations were determined using 
an enzyme-linked immunoassay. Concentrations of 
MMP-3, -9 and -13 and TIMP-1, -2, -3 and -4 were 
assessed using a Human Matrix Metalloproteinases 
3-Plex Panel and Human TIMP Multiplex Kit. Mul-
tiple proteins were analysed using a multiplex bead 
immunoassay (Human Cytokine 30-plex Panel). All 
multiplexes were run on a Luminex 200 platform 
equipped with Bio-Plex software.
Statistical analysis
Univariate group differences were tested with χ² 
or Fisher’s Exact test for categorical and Mann-
Whitney U-test or Student’s t-test for continuous 
variables. As multiple markers were considered as 
outcome variables (e.g. multiplexes), we accounted 
for multiple testing by applying the Bonferroni 
correction: where appropriate, adjusted p-values 
were obtained by multiplying with the total 
number of markers and ratios and used to evaluate 
significance. The normality of the continuous data 
was tested using the Kolmogorov-Smirnov test and 
visual inspection of QQ-plots. Since the distribution 
of inflammatory markers were positively skewed, 
their natural log transformed values were used so 
as to have a normally distributed outcome variables 
for the multiple regression analysis, which was 
performed on the full dataset.
Table II — Overview of the study population and immunoassays for the different inflammatory markers.
Inflammatory
marker
Study population Immunoassay
Total 
patients
Group 1
PTB
Group 2
GA matched 
controls
Group 3
AT in 
labour
Group 4
AT not in 
labour
sTREM-1 176 52 52 40 32 ELISA R&D systems, Minneapolis, MN
MMP-9 166 47 47 40 32 Luminex Human Matrix Metalloproteinases 
3-Plex Panel*
Invitrogen, Inc. Carlsbad, CA
TIMP-1 to -4 166 47 47 40 32 Luminex Human TIMP Multiplex Kit
R&D systems, Minneapolis, MN
MMP-3 116 34 34 27 21 Luminex Human Matrix Metalloproteinases 
3-Plex Panel
Invitrogen, Inc. Carlsbad, CA
Multiplex 144 39 39 34 32 Luminex Human Cytokine 30-plex Panel**
Invitrogen, Inc. Carlsbad, CA
*The 3-plex was validated for serum by performing spike and recovery and linearity-of-dilution experiments. MMP-
13 concentrations in maternal serum were undetectable in all samples using this method. At a twofold dilution of serum, 
concentrations were below the detection limit and recovery fell outside the range 70-130%.
** The panel consisted of epidermal growth factor (EGF), eotaxin, basic fibroblast growth factor (FGF-basic), granulocyte 
colony-stimulating factor (G-CSF), granulocyte macrophage colony-stimulating factor (GM-CSF), hepatocyte growth 
factor (HGF), interferon alpha (IFN-α), interferon gamma (IFN-γ), interleukin (IL) receptor antagonist (IL-1RA), IL-1β, 
IL-2, soluble IL-2 receptor (sIL2R), IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p40/p70), IL-13, IL-15, IL-17, inducible 
protein-10 (IP-10), monocyte chemoattractant protein (MCP)-1, monokine induced by gamma interferon (MIG), macrophage 
inflammatory protein (MIP)-1α, MIP-1β, Regulated on Activation, Normal T-cell Expressed and Secreted (RANTES), tumor 
necrosis factor alpha (TNF-α), and vascular endothelial growth factor (VEGF).
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centrations among the different groups. Significant-
ly higher median concentrations of sTREM-1 were 
seen in women with PTB compared to GA matched 
controls (p < 0.001). Median sTREM-1 concentra-
tions were significantly increased in women AT in 
labour compared with AT not in labour (p < 0.001). 
Results
Demographic and clinical characteristics of the 
study population
As shown in Table II, the number of included 
women varied among the different immunological 
analyses, but in general the population character-
istics were similar. No significant differences were 
found regarding pre-pregnancy BMI, marital status, 
ethnicity, conception, parity and history of PTB. 
Women with PTB had significantly lower education 
levels than GA matched controls. There were sig-
nificantly more smokers among women with PTB 
compared to women AT in labour. Significant dif-
ferences were also found in maternal age and the 
proportion of smokers between women AT in labour 
vs. AT not in labour. Table III summarizes maternal 
and obstetrical characteristics of the study popula-
tion for sTREM-1 determination.
Evaluation of sTREM-1 levels in maternal serum
sTREM-1 was detected in all serum samples col-
lected in the study. Figure 1 shows sTREM-1 con- Fig. 1. — Serum sTREM-1 concentrations among groups. Horizontal bars denote the median value for each study group.
Table III. — Demographic and clinical characteristics of the study population (sTREM-1).
Variables PTB
(n = 52)
GA matched 
controls (n = 52)
AT in labor
(n = 40)
AT not in labor
(n = 32)
Pa Pb Pc
Maternal age (mean ± SD, y)
Pre-pregnancy BMI (Me, IQR, kg/m2)
Educational level (n, %)
Secondary education or less
Higher education
Marital status (n, %)
Married or cohabiting
Living alone
Smoking at recruitment
Ethnicity (n, %)
White/Caucasian
Other
GA at recruitment (Me, IQR, wk)
Conception (n, %)
Spontaneous
Assisted reproductive technology
Nullipara (n, %)
History of PTB
GA at delivery (Me, IQR, wk)
Delivery mode (n, %)
Vaginal birth
Caesarean section
Birth weight (mean, ±SD, g)
Gender (n, %)
•
•
28.7 ± 5.6
21.5 [19.7-24.8]
24 (46.2)
28 (53.8)
47 (92.2)
4 (7.8)
9 (17.3)
51 (98.1)
1 (1.9)
29.0 [26.0-31.0]
44 (84.6)
8 (15.4)
32 (61.5)
4 (7.7)
30.0 [28.0-32.0]
48 (92.3)
3 (5.9)
1517.3 ± 514.4
16 (30.8)
36 (69.2)
29.8±4.1
21.8 [20.1-23.1]
9 (17.3)
43 (82.7)
48 (94.1)
3 (5.9)
8 (15.4)
50 (96.2)
2 (3.8)
29.0 [26.0-31.0]
45 (86.5)
7 (13.5)
26 (50.0)
2 (3.8)
40.0 [39.0-40.0]
43 (84.3)
8 (15.7)
3484.9 ± 498.0
26 (51.0)
25 (49.0)
29.1 ± 4.6
21.9 [19.9-24.0]
11 (27.5)
29 (72.5)
39 (97.5)
1 (2.5)
0 (0.0)
36 (90.0)
4 (10.0)
40.0 [39.0-40.0]
34 (85.0)
6 (15.0)
20 (50.0)
2 (5.0)
40.0 [39.0-40.0]
39 (97.5)
1 (2.5)
3461.9 ± 396.2
21 (52.5)
19 (47.5)
31.4 ± 4.4
21.6 [19.9-25.0]
7 (21.9)
25 (78.1)
31 (96.9)
1 (3.1)
4 (12.5)
32 (100.0)
0 (0.0)
38.0 [38.0-39.0]
31 (96.9)
1 (3.1)
12 (37.5)
1 (3.1)
38.0 [38.0-39.0]
0 (0.0)
32 (100.0)
3236.9 ± 360.0
18 (56.3)
14 (43.8)
P = 0.26
P = 0.98
P = 0.002
P = 0.70
P = 0.79
P = 1.00
P = 1.0
P = 0.78
P = 0.24
P = 0.68
P < 0.001
P = 0.21
P < 0.001
P = 0.04
P = 0.03
P = 0.43
P = 0.58
P = 1.00
P = 0.04
P = 0.12
P < 0.001
P = 0.09
P = 0.29
P = 1.00
P < 0.001
P < 0.001
P = 0.01
P = 0.75
P = 0.69
P = 0.77
P = 0.09
P = 0.38
P = 0.005
P = 0.16
P < 0.001
P = 0.96
P = 0.27
P = 0.69
P < 0.001
P = 0.38
P < 0.001
P = 0.04
a PTB vs. GA matched controls; b AT in labor vs. AT not in labor; c PTB vs. AT in labor.
SD, standard deviation; BMI, body mass index; Me, Median; IQR, interquartile range; GA, gestational age; PTB, preterm birth; 
AT, at term.
Group differences were evaluated with Fisher’s Exact test for categorical variables and Mann-Whitney U-test for continuous 
variables.
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9:TIMP-1 and MMP-9:TIMP-2 ratio was observed 
in women with PTB (p  =  0.006 resp. p < 0.001). 
Higher MMP-9 and lower TIMP-1 concentrations 
were observed in women with PTB, but these 
differences were only weakly significant (p = 0.07 
resp. p = 0.09).
Multiple regression analysis was performed on 
the full dataset. The R2 of our regression models 
varied from 7 to 33%, indicating a large amount of 
variation in log marker concentration not explained 
by the covariates included. Our regression results 
showed that, after adjusting for other covariates, 
MMP-9 and all MMP-9:TIMP ratios were signifi-
cantly higher for preterm (vs. at term, p < 0.001), 
whereas TIMP-1 and TIMP-2 were significantly 
lower for preterm (p = 0.002 resp. p < 0.001). The 
regression model showed that MMP-9 concentra-
tions and MMP-9:TIMP-2 ratios were significant-
ly higher for labour (vs. no labour, p = 0.03 resp. 
p = 0.04), the same was true for TIMP-4 concentra-
tions (p < 0.001). Regression results show no sig-
nificant association between pretermor labourstatus 
and MMP-3 or any of the MMP-3:TIMP ratios. 
Evaluation of multiple biomarkers in maternal 
serum
Of the 30 inflammatory markers analysed, only 8 
were detectable in more than 50% of the maternal 
serum samples: EGF, HGF, IL-12, eotaxin, MIP-
1β, MCP-1, IP-10 and sIL-2R. Concentrations of 
RANTES were all outside the linear range. Levels 
of the other 21 inflammatory markers were below 
the detection limits of the assay in more than 50% 
of samples in all groups. To avoid biased results 
in subsequent statistical analyses, these censored 
values were imputed at half the detection limit.
Women with PTB had significantly higher sTREM-1 
levels than women AT in labour (p = 0.004).
The regression model (Table IV) showed that 
labour (vs. not in labour) and preterm (vs. not 
preterm) remained significantly associated with 
sTREM-1 concentration after adjusting for edu-
cational level, history of PTB and sample age. On 
average, the sTREM-1 concentration was 30% 
higher in labour (vs. not in labour) and 15% higher 
preterm (vs. at term). 
Evaluation of serum MMP-9, MMP-3 and TIMP-1 
to -4 levels as well as MMP:TIMP balances
MMP-3, TIMP-1, TIMP-2 and TIMP-4 were de-
tectable in all serum samples, MMP-9 in 97.2% and 
TIMP-3 in only 26.7% of samples. Serum MMP-
9 concentrations of 4 samples (all patients from 
the PTB group) were outside the linear range and 
TIMP-3 levels were below detection limits of the 
assay in most samples (75.3%). Therefore these val-
ues were omitted from further analyses. MMP-13 
could not be assessed in serum. Serum MMP-3 and 
-9, TIMP-1, -2 and -4 concentrations and their ratios 
are summarized in Table V. 
Median levels of MMP-9 and TIMP-4 were 
significantly higher in women with PTB compared 
to GA matched controls (p = 0.001 resp. p < 0.001). 
The same was true for median MMP-9:TIMP-1 and 
MMP-9:TIMP-2 ratios (p < 0.02 resp. p < 0.001).
No significant differences in MMP-9, MMP-3, 
all TIMP concentrations or any of the MMP:TIMP 
ratios were observed between women AT in labour 
vs. AT not in labour. 
Median TIMP-2 levels were significantly lower 
in women with PTB compared to those AT in 
labour (p < 0.001). A significant higher MMP-
Table IV. — Multiple regression model for ln(sTREM-1 concentration).
Parameter Model coefficient
(95%CI)
Exponentiated coefficient
(95%CI)
P-value
Intercept
Preterm [vs. at term]
Labor [vs. not in labor]
ROM [vs. intact membranes]
Secondary education (or less) [vs. higher education]
History of PTB [vs. no history]
Sample age (in hours)
5.416 [5.323, 5.508]
0.142 [0.043, 0.241]
0.258 [0.126, 0.391]
-0.021 [-0.156, 0.113]
0.128 [0.020, 0.236]
-0.324 [-0.542, -0.105]
0.0039 [0.0003, 0.0076]
224.9 [205.1, 246.7]
1.152 [1.044, 1.272]
1.295 [1.134, 1.479]
0.979 [0.856, 1.120]
1.136 [1.020, 1.266]
0.724 [0.582, 0.900]
1.004 [1.000, 1.008]
< 0.001
0.005
< 0.001
0.76
0.02
0.004
0.04
Results of the model fitted on the full dataset (n = 176), obtained from the backward selection procedure outlined in the 
text. Covariates considered but not retained were: maternal age, marital status, smoking, body mass index and storage time. 
Coefficients of the model (additive on the log scale) were exponentiated to multiplicative factors, allowing interpretation on 
the concentration scale.
Sample age = time delay between blood sampling and processing
ROM, rupture of the membranes; PTB, preterm birth; CI, confidence interval
R²=0.28
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served no similar significant association of preter-
mor labour status with any of the other 7 markers. 
Discussion 
Elevated sTREM-1 levels in maternal serum during 
term and preterm labour
In line with previous observations in amniotic 
fluid (Kusanovic et al., 2010), serum sTREM-1 
levels were significantly increased in women with 
preterm labour compared to GA matched controls. 
We also observed elevated sTREM-1 concentrations 
during spontaneous term parturition vs. non 
labouring controls. This observation is consistent 
with Youssef et al. who demonstrated increased 
TREM-1 RNA expression in myometrium and 
cervix after labour at term (Youssef et al., 2009). In 
contrast, no differences were observed in amniotic 
fluid concentrations of sTREM-1 between labouring 
and non-labouring women at term (Kusanovic et 
Median levels of EGF and HGF were significantly 
higher in women with PTB compared to GA matched 
controls (respectively p < 0.01 and p < 0.05). A 
significantly lower median IL-12 concentration was 
observed in women AT in labour compared to AT 
not in labour (p < 0.05). 
Median IL-12, eotaxin and IP-10 were signifi-
cantly lower in women with PTB compared to 
AT in labour (respectively p < 0.01, p < 0.05 and 
p < 0.01). Lower median MCP-1 levels were ob-
served in women with PTB, although this difference 
was marginally not significant (p = 0.05). 
Multiple regression analysis was performed on 
the full dataset. The R2 of our regression models 
varied from 10 to 39%, indicating a large amount 
of variation in log marker concentration not ex-
plained by the covariates included. Our regression 
results showed that, after adjusting for other covari-
ates, average IP-10 concentrations were 47% lower 
preterm (vs. at term, p < 0.001) and average IL-12 
concentrations were 23% lower in labour. We ob-
Table V. — Comparison of MMP-3, MMP-9, TIMPs levels and MMP:TIMPs ratios in maternal serum among groups.
Group 1
PTB
(n = 47)
Group 2
GA matched controls
(n = 47)
Group 3
AT in labor
(n = 40)
Group 4
AT not in labor
(n =32)
Group 1 vs. 2
P-value$
Group 3 vs. 4
P-value$
Group 1 vs. 3
P-value$
MMP-9 1125.1
[694.1-1977.4]
639.5   
[513.8-924.5]
828.7   
[420.7-1259.8]
554.6   
[377.5-711.3]
< 0.001 
(0.001)
0.06 
(NS)
0.006 
(0.07)
TIMP-1 132.04
[118.25-152.27]
125.65 
[111.07-139.21]
149.49 
[133.01-185.46]
137.98 
[125.18-149.44]
0.08   
(NS)
0.02 
(NS)
0.008   
(0.09)
TIMP-2 121.76
[107.62-132.19]
121.26 
[109.35-135.82]
156.12 
[139.67-190.19]
137.71 
[124.57-164.27]
0.68   
(NS)
0.03 
(NS)
< 0.001 
(< 0.001)
TIMP-4 1.46
[1.09-1.96]
1.04     
[0.83-1.26]
1.24     
[1.12-1.46]
1.08     
[0.81-1.35]
0.001 
(< 0.001)
0.01 
(NS)
0.08     
(NS)
MMP-9:TIMP-1 
ratio
8.21
[4.82-13.88]
5.26     
[3.89-7.09]
4.85     
[2.86-8.98]
3.94     
[3.07-5.33]
0.002  
(0.02)
0.35 
(NS)
0.001   
(0.006)
MMP-9:TIMP-2 
ratio
9.68
[6.06-14.34]
5.23     
[3.95-7.35]
4.61     
[2.80-6.75]
3.69     
[2.92-5.45]
0.001  
(< 0.001)
0.26 
(NS)
< 0.001 
(< 0.001)
MMP-9:TIMP-4 
ratio
847.3
[386.8-1463.3]
657.4   
[434.0-995.9]
578.0   
[342.7-980.3]
567.7   
[337.6-765.7]
0.29    
(NS)
0.57 
(NS)
0.13     
(NS)
PTB
(n = 34)
GA matched controls
(n = 34)
AT in labor
(n = 27)
AT not in labor
(n = 21)
P-value$ P-value$ P-value$
MMP-3 9.10
[5.83-15.53]
8.78   
[4.68-14.97]
9.55   
[3.96-15.83]
7.14   
[4.76-13.46]
0.55 
(NS)
0.76 (NS) 0.52 
(NS)
MMP-3:TIMP-1 
ratio
0.065
[0.046-0.111]
0.065 
[0.032-0.136]
0.062 
[0.033-0.108]
0.057 
[0.035-0.093]
0.60 
(NS)
0.88 
(NS)
0.25 
(NS)
MMP-3:TIMP-2 
ratio
0.073
[0.058-0.118]
0.074
[0.041-0.111]
0.048 
[0.031-0.103]
0.045 
[0.030-0.102]
0.47 
(NS)
0.99 
(NS)
0.03 
(NS)
MMP-3:TIMP-4 
ratio
6.13
[3.86-12.40]
7.95
[4.84-13.37]
8.45   
[3.94-11.37]
7.36   
[4.06-11.37]
0.44 
(NS)
0.96 
(NS)
0.74 
(NS)
Results are expressed as median (interquartile range) (ng/ml), group differences were evaluated with the Mann-Whitney U-test
PTB, preterm birth; PT, preterm; AT, at term; NS, not significant
$ Unadjusted P values and Bonferroni-adjusted P values (adjusted for 11 tests) between brackets
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Little is known about the role of TIMP-4 during 
pregnancy and parturition. It has been shown that 
TIMP-4 is involved in reproductive processes and 
cancers (Chegini et al., 2003; Melendez-Zajgla et 
al., 2008; Pilka et al., 2006). We found that TIMP-
4 levels were elevated during labour (either term 
or preterm), but changes in MMP-9:TIMP-4 ratio 
were not significant. This may be related to the 
relatively low sample size of the study, but may 
also be explained by the different potency of TIMP-
4 against different MMPs. It has been shown that, 
although TIMP-4 effectively inhibits MMP-9, it 
has the highest affinity for MMP-26 (Zhang et al., 
2002). It would be interesting to investigate whether 
higher MMP-26:TIMP-4 ratios are associated with 
preterm labour.
Importantly, our study showed that MMP-
9:TIMP-1 and MMP-9:TIMP-2 ratios were sig-
nificantly higher in women with preterm labour, 
indicating a ratio shift towards matrix degrada-
tion.Previous studies in amniotic fluid and in vitro 
studies on foetal membranes demonstrated imbal-
ances between MMPs and TIMPs during PPROM. 
Fortunato et al. (1999) found that the molar ratio 
between MMP-2 and TIMP-2 in amniotic fluid was 
increased during PPROM. Our finding of MMP-
9:TIMP imbalances in maternal serum, tilting the 
balance toward matrix degradation, deserves fur-
ther consideration. It has been shown that MMP-9 
is detectable in serum approximately 24 hours be-
fore the initiation of labour or PPROM (Goldenberg 
et al., 2005), so probably the same is true for the 
MMP-9:TIMP ratio, thereby limiting the time to 
initiate an intervention. In conclusion, our results 
indicate that circulating MMPs and TIMPs may 
play a role in the pathogenesis of preterm labour 
at systemic level and suggest that a far less inva-
sive approach could be developed for the measure-
ment of enzymes essential for ECM remodelling 
during pregnancy and parturition. However, further 
research is needed to determine the temporal rela-
tionship between MMP:TIMP ratio shift and PTB 
as well as the involvement of other members of the 
MMP family in pregnancy and (preterm) labour.
Multiple biomarkers in maternal serum in women 
with term and preterm labour
Finally, we evaluated a biomarker panel in maternal 
serum during term and preterm labour. Among the 
30 inflammatory markers we studied, only EGF and 
HGF levels were associated with preterm labour. 
However, the multiple regression model for EGF 
showed that sample age may act as a confounding 
factor. It has been demonstrated that EGF levels 
are higher in serum than those measured in 
al., 2010). These data suggest that the maternal 
inflammatory response during labour may be 
different form the foetal response. We also found 
higher sTREM-1 levels in women with preterm 
labour compared to term labour. The increased 
circulating sTREM-1 levels during preterm labour 
may indicate a contributory role of sTREM-1 in 
infectious-associated PTB and is in agreement with 
previous studies who demonstrated that sTREM-1 
may play a role during preterm parturition and 
IUI (Cobo et al., 2012; Holst et al., 2011; Kusanovic 
et al., 2010; Menon and Fortunato, 2008). 
Our observations support the involvement of an 
inflammatory process in human parturition (either 
term or preterm). However, additional research 
is recommended to explore the role of sTREM-1 
during pregnancy and labour and to assess the 
usefulness of sTREM-1 as diagnostic and prognostic 
biomarker in maternal blood of both symptomatic 
and asymptomatic patients compared with standard 
of care.
Imbalances between MMPs and TIMPs in maternal 
serum during preterm labour
The role of MMPs in human term and preterm par-
turition, and to a lesser extent that of TIMPs, have 
been widely investigated over the past decades. The 
novelty of our study regards the determination of 
MMP-3, MMP-9 and all four TIMPs in maternal se-
rum as well as the MMP:TIMP ratios. In line with 
previous observations in maternal plasma and am-
niotic fluid (Makrakis et al., 2003; Maymon et al., 
2000) we found elevated MMP-9 concentrations in 
maternal serum during preterm labour. Human par-
turition (either term or preterm) was not associated 
with changes in serum MMP-3 concentration in our 
study. In contrast, MMP-3 levels in amniotic fluid 
were elevated during spontaneous labour at term 
and preterm (Park et al., 2003).
A fully functional TIMP network has been 
demonstrated in human foetal membranes, placenta 
and decidua and in second trimester amniotic 
fluid (Fortunato et al., 1998; Riley et al., 1999). To 
the best of our knowledge, we demonstrated for 
the first time that all four TIMPs were expressed in 
maternal serum. Levels TIMP-1 and TIMP-2 were 
lower during gestation compared to term gestation, 
irrespective of labour status. This is in agreement 
with Clark et al., who demonstrated that TIMP-1 is 
suppressed during pregnancy with increasing serum 
levels from 37 weeks onwards, back to pre-pregnant 
levels (Clark et al., 1994). The similar observation 
was made in amniotic fluid for TIMP-2 showing an 
increase in concentration with advancing gestational 
age (Athayde et al., 1998). 
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plasma, which may be attributed to platelet derived 
EGF (Yucel et al., 2007). Therefore, the value of 
EGF as non-invasive marker for preterm labour 
seems to be limited. To our knowledge, no other 
studies investigated HGF serum levels during labour. 
Although group comparison showed higher HGF 
levels in preterm labour, none of the key covariates 
were significant in the multiple regression models. 
Large studies are needed to confirm the possible 
role of HGF in the onset of preterm labour. 
We observed lower IL-12 levels in labouring 
women, irrespective of gestational age (term or 
preterm). Our results are in agreement with those 
of Dubicke et al. (2010) who demonstrated that 
mRNA IL-12 was downregulated in cervical tissues 
of labouring women and expression was lower in 
preterm than in term labour. These data are contrary 
to the classical Th1:Th2 paradigm, which assumes 
that a Th1 response is associated with adverse 
pregnancy outcomes.However, it has been shown 
that IL-12 can interact synergistically with IL-18 
to provoke a Th1 response. Therefore, the cytokine 
balance may be of greater importance than the 
absolute concentrations. High IL-12:IL-18 ratios 
in women with preterm labour were associated 
with a twofold increased risk for delivery before 
34 weeks (Ekelund et al., 2008). Few studies have 
reported the relation between IP-10 and preterm 
labour. We observed higher IP-10 levels in term 
gestation, irrespective of labour. This is in line with 
Kraus et al. who observed increasing IP-10 levels in 
maternal blood with advancing gestational age(Kraus 
et al., 2010). It has been demonstrated that amniotic 
fluid levels of IP-10 were elevated in preterm 
labour cases with chronic chorioamnionitis (Ogge 
et al., 2011). It would be interesting to investigate 
whether chronic chorioamnionitis is associated with 
an altered chemokine profile in maternal blood.
Our study has several strengths. First, we evaluated 
several biomarkers in maternal serum which can 
be easily obtained during pregnancy. Secondly, we 
determined biomarkers in women with either term 
or preterm labour vs. non-labouring controls. The 
mechanisms of preterm labour are largely unknown, 
at least in part because the process of term labour 
is poorly understood. Further understanding of the 
inflammatory processes during labour is essential 
for the development of novel and effective therapies 
to block preterm labour (Hamilton et al., 2012). 
Another strength of our study is that we performed 
multiple regression analysis to determine the effect 
of three key covariates (preterm vs. at term, labour 
vs. no labour, ROM vs. intact membranes) and to 
adjust for possible confounding effects by other 
covariates including important risk factors of 
PTB, sample age and storage time. When multiple 
biomarkers were considered, we also accounted 
for the number of tests by applying Bonferroni 
correction. Finally, our analyses were performed 
by using multiplex technology, when commercially 
available. This novel technological approach makes 
it possible to measure multiple proteins simulta-
neously in a minimal amount of biological sample. 
This is important, because it is increasingly 
accepted that single biomarkers lack effectiveness 
to accurately predict PTB (Menon et al., 2011). 
Despite these strengths, some limitations of 
our study deserve consideration. First, we only 
evaluated maternal biomarkers in serum, mainly 
because of the non-invasive approach, but also 
because amniocentesis and placental and foetal 
membrane histology are not standard of care in 
our institution. Hence, our PTB group represents 
a quite heterogeneous group of patients, because 
information on foetal or placental conditions was 
lacking. Secondly, the study was conducted in 
a single institution which prevented the use of a 
larger sample size; hence the number of women 
was inadequate for extensive subgroup analysis. An 
interesting subgroup analysis would be to evaluate 
whether biomarker levels differ between women 
with preterm labour and intact membranes who 
delivered preterm vs. those with term delivery. 
Finally, the nested case control design does not 
allow us to evaluate the accuracy of the analysed 
inflammatory markers to predict PTB. A large 
multicentre prospective cohort study is needed to 
investigate the predictive value of these biomarkers 
in maternal blood and PTB in asymptomatic 
women (before preterm labour) and to develop 
valuable combined multivariable prediction models. 
Conclusion 
Until present, few biomarkers have shown clinical 
usefulness, because they are nonspecific or become 
positive too late. Among the biomarkers evaluated 
to date, the most powerful and consistent predictors 
of PTB are the presence of foetal fibronectin 
in cervicovaginal fluid and a short cervix on 
transvaginal ultrasound. The clinical value of both 
tests primarily lies in their negative predictive value 
thereby guiding clinicians in decision-making and 
avoiding unnecessary interventions. During the 
last decades, it has become clear that single or 
universal biomarkers will not be capable to predict 
PTB accurately in all populations. Future research 
should focus on multiple biomarkers in different 
PTB subtypes to allow differentiation depending 
on the underlying causes. The future development 
of an accurate, minimally invasive multiple 
marker test is necessary to permit incorporation 
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